Knowledge toward Drugs Resistant Tuberculosis in One of the Highest Burden Drug Resistant Country

Amalia Rizki Ramadhani; Bony Wiem Lestari; Hendarsyah Suryadinata

doi:10.15850/amj.v4n3.1610

Knowledge toward Drugs Resistant Tuberculosis in One of the Highest Burden Drug Resistant Country

Amalia Rizki Ramadhani, Bony Wiem Lestari, Hendarsyah Suryadinata

Abstract

Background: Drug resistant tuberculosis (DR-TB) is the biggest threat in TB case control worldwide. West Java Province is one of the three provinces with the most DR-TB burden in Indonesia. Knowledge level in DR-TB patients influences the perception, health search effort, and patient compliance towards DR-TB treatment. This study was aimed to identify the knowledge level about DR-TB in DR-TB patients at Hasan Sadikin General Hospital.

Methods: This cross-sectional, descriptive quantitative study used consecutive sampling. In the study 96 patients were included. Primary data were collected through interview with questionnaire towards DR-TB patients at MDR-TB Clinic Hasan Sadikin General Hospital during September-November 2016. The questionnaire contained sociodemographic data and knowledge about DR-TB which consisted of definition, transmission, risk factors, resistance types, symptoms, medication, and prevention of DR-TB. The collected data were analyzed using statistical software for descripitive statistical analysis.

Results: The average age of patients was 38 years (SD±11.7) and mostly ranging from 36–45 years old. Male had a higher distribution compared to female (55.2%). Analysis results showed 20% patients had “Adequate” knowledge level, 34.4% of the patients had “Sufficient” knowledge, and 39.6% of the patients had “Poor” knowledge about DR-TB.

Conclusions: DR-TB patients at MDR-TB Clinic Dr. Hasan Sadikin General Hospital Bandung have “poor” knowledge regarding DR-TB.

Keywords

Drug Resistant TB; knowledge; patients

Full Text:

PDF

References

World Health Organization. Global tuberculosis report 2013. Geneva: WHO Press; 2015.

Van den Hof S, Collins D, Hafidz F, Beyene D, Tursynbayeva A, Tiemersma E, et al. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan. BMC Infect Dis. BMC Infectious Diseases; 2016;16(1):470–84.

Nugroho RA. Studi kualitatif faktor yang melatarbelakangi drop out pengobatan tuberkulosis paru. J Kesehat Masy. 2011;7(1):83–90.

Oblast A, Smith SE, Ershova J, Vlasova N, Nikishova E, Tarasova I, et al. Risk factors for acquisition of drug resistance during multidrug-resistant tuberculosis. Emerg Infect Dis. 2015;21(6):1002–11.

Kementerian Kesehatan RI. Petunjuk teknis manajemen terpadu pengendalian tuberkulosis resistan obat. Jakarta: Kemenkes RI; 2013.

Manika D, Golden LL. Advances in prior knowledge conceptualizations: investigating the impact on health behavior. In: Plangger K, editor. Thriving in a New World Economy. 4th ed. London: Springer; 2015. p. 319–29.

Bam K, Bhatt LP, Thapa R, Dossajee HK, Angdembe MR. Illness perception of tuberculosis (TB) and health seeking practice among urban slum residents of Bangladesh: a qualitative study. BMC Res Notes. 2014;7(1):572–8.

Fox GJ, Loan LP, Nhung NV, Loi NT, Sy DN, Britton WJ, et al. Barriers to adherence with tuberculosis contact investigation in six provinces of Vietnam: a nested case-control study. BMC Infect Dis. 2015;15(1):103–11.

Myet H, Maung W, Saw S, Oo WM. Knowledge and practice on MDR-TB disease among MDR-TB patients attending Aung San MDR-TB Clinic (Yangon). Myanmar Heal Sci Res J. 2015;27(1):77–82.

Kementerian Kesehatan RI. Laporan situasi perkembangan TB MDR di Indonesia Triwulan II Tahun 2015. Jakarta: Kemenkes RI; 2015.

Li Y, Ehiri J, Oren E, Hu D, Luo X, Liu Y, et al. Are we doing enough to stem the tide of acquired MDR-TB in countries with high TB burden? Results of a mixed method study in Chongqing, China. PLoS One. 2014;9(2):1–12.

Tang S, Tan S, Yao L, Li F, Li L, Guo X, et al. Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation. PLoS One. 2013;8(12):1–8

Tupasi TE, Marie A, Garfin CG, Kurbatova E V, Mangan JM, Orillaza-chi R, et al. Factors associated with loss to follow-up during treatment for multidrug-resistant tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis. 2016;22(3):491–502.

Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15(2):368–77.

Ullah I, Javaid A, Tahir Z, Ullah O, Shah AA, Hasan F, et al. Pattern of drug resistance and risk factors associated with development of drug resistant Mycobacterium tuberculosis in Pakistan. PLoS One. 2016;11(1):1–7

Liu Q, Zhu L, Shao Y, Song H, Li G, Zhou Y, et al. Rates and risk factors for drug resistance tuberculosis in Northeastern China. BioMed Cent Ltd. 2013;13(1171):1–7.

Nair SA, Raizada N, Sachdeva KS, Denkinger C, Schumacher S, Dewan P, et al. Factors associated with tuberculosis and rifampicin-resistant tuberculosis among symptomatic patients in India: a retrospective analysis. PLoS One. 2016;11(2):1–9.

Elmi OS, Hasan H, Abdullah S, Mat Jeab MZ, Bin Alwi Z, Naing NN. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. J Infect Dev Ctries. 2015;9(10):1076–85.

Daniel O, Osman E. Prevalence and risk factors associated with drug resistant TB in South West, Nigeria. Asian Pac J Trop Med. 2011;4(2):148–51.

Maharaj J, Ross A, Maharaj NR, Campbell L. Multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa: an overview of patients’ reported knowledge and attitudes. African J Prim Heal care Fam Med. 2016;8(1):1–6.

DOI: https://doi.org/10.15850/amj.v4n3.1610